Implications of Ethics Determinant on Dentistry and Pharmacy Research

Implications of Ethics Determinant on Dentistry and Pharmacy Research: A Study of IRB Perspective

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05195671

Enrollment

131

Registered

2022-01-19

Start date

2021-10-01

Completion date

2021-12-10

Last updated

2022-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Review, Research Peer

Keywords

Dental Ethics, Pharmacy Ethics, Institutional Ethics Committees

Brief summary

The ethical review of dental and pharmacy research protocols has its own challenges facing the institutional ethical committees. Seemingly low risk procedure might pose controversies among committees' members. The aim of this article is to describe some of the ethical concerns, particular to dental and pharmacy research that an ethics committee could face while reviewing dental research.

Detailed description

The investigators have read all protocols submitted to the MIU IRB and reviewed all meetings' minutes to outline the ethical concerns that warranted discussions in the meetings, and how the committee came to a resolution for those concerns.

Interventions

OTHERReview

Reviewing all protocols

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* all protocols submitted to IRB

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Ethical concerns	1 month	Frequencies and percentages of ethical concerns

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026